H. Lundbeck A/S (OTCMKTS:HLUYY – Get Free Report) crossed below its 50 day moving average during trading on Thursday . The stock has a 50 day moving average of $22.00 and traded as low as $22.00. H. Lundbeck A/S shares last traded at $22.00, with a volume of 7,500 shares changing hands.
H. Lundbeck A/S Price Performance
The firm has a 50 day moving average of $22.00 and a two-hundred day moving average of $22.00. The company has a market cap of $21.91 billion, a PE ratio of 25.00 and a beta of 0.68. The company has a current ratio of 1.15, a quick ratio of 0.71 and a debt-to-equity ratio of 0.32.
About H. Lundbeck A/S
H. Lundbeck A/S, a biopharmaceutical company, engages in the research, development, production, and sale of pharmaceuticals for the treatment of psychiatric and neurological disorders in Europe, North America, and internationally. The company's principal products include Abilify Maintena for schizophrenia; Brintellix/Trintellix to treat depression; Northera for the treatment of symptomatic neurogenic orthostatic hypotension; Vyepti for migraine prevention; and Rexulti/Rxulti to treat depression/schizophrenia.
Further Reading
- Five stocks we like better than H. Lundbeck A/S
- How to Calculate Options Profits
- Buffett Takes the Bait; Berkshire Buys More Oxy in December
- What Are Dividends? Buy the Best Dividend Stocks
- Top 3 ETFs to Hedge Against Inflation in 2025
- Russell 2000 Index, How Investors Use it For Profitable Trading
- These 3 Chip Stock Kings Are Still Buys for 2025
Receive News & Ratings for H. Lundbeck A/S Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for H. Lundbeck A/S and related companies with MarketBeat.com's FREE daily email newsletter.